Who owns ANI PHARMACEUTICALS INC (ANIP)? Elite investor 13F holders

4 tracked elite investors reported holding ANI PHARMACEUTICALS INC as of 2026-06-30, including Rubric Capital, D.E. Shaw, Renaissance Technologies LLC, Gotham Asset Management. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

4 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and…

Reported holders and securities, including exits (up to 20)

Reported holders and securities, including exits (up to 20)
InvestorSecurityInstrumentReport periodFiledValueQuantityUnitsChangeSource
Rubric CapitalANI PHARMACEUTICALS INCSHARE2026-06-302026-08-14 00:00:0021368084.00 USD258131.000000SharesbuyOriginal filing
D.E. ShawANI PHARMACEUTICALS INCSHARE2026-06-302026-08-14 00:00:0014464315.00 USD174732.000000SharesreduceOriginal filing
Renaissance Technologies LLCANI PHARMACEUTICALS INCSHARE2026-06-302026-08-13 00:00:005273086.00 USD63700.000000SharesreduceOriginal filing
Gotham Asset ManagementANI PHARMACEUTICALS INCSHARE2026-06-302026-08-14 00:00:00498915.00 USD6027.000000SharesreduceOriginal filing
Polen Capital ManagementANI PHARMACEUTICALS INCSHARE2026-06-302026-08-04 00:00:000.00 USD0.000000SharesexitedOriginal filing

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

How to read the data · Disclaimer

Read as Markdown